ABSTRACT The pulmonary hypertensive response to pulmonary vascular obstruction caused by intravenously injected microparticles is amplified by pretreatment with N ω nitro-L-arginine methyl ester (L-NAME). The L-NAME prevents the synthesis of the potent vasodilator nitric oxide (NO) by inhibiting both the constitutive [endothelial NO synthase (eNOS or NOS-3)] and inducible [inducible NO synthase (iNOS or NOS-2)] forms of NO synthase. In the present study we used the selective iNOS inhibitor aminoguanidine (AG) to evaluate the role of iNOS in modulating the pulmonary hypertension (PH) triggered by microparticle injections. Experiment 1 was conducted to confirm the ability of AG to inhibit NO synthesis by iNOS in broiler peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide (LPS, endotoxin). Mononuclear leukocytes treated with LPS produced 10-fold more NO than untreated (control) cells. The LPSstimulated production of NO was partially inhibited by L-NAME and was fully inhibited by AG, thereby confirming that AG inhibits LPS-mediated iNOS activation in broilers. In Experiment 2 we evaluated the responses of male progeny from a base population (MP Base) and from a derivative line selected for one generation from the
INTRODUCTION
Broilers are susceptible to pulmonary hypertension syndrome (PHS, ascites) when their pulmonary vascular capacity is anatomically or functionally inadequate to accommodate the requisite cardiac output (Peacock et al., 1989 (Peacock et al., , 1990 Wideman and Bottje, 1993; Wideman, 1999 Wideman, , 2000 Wideman, , 2001 Wideman et al., 1 US patent 6,720,473 protects the exclusive rights of the University of Arkansas to all uses of the intravenous microparticle injection technology within the context of evaluating or affecting the pulmonary vascular capacity, pulmonary vascular resistance, pulmonary hypertension, cardiopulmonary hemodynamics, and susceptibility to pulmonary hypertension syndrome (ascites) in domesticated animal species. 2 Corresponding author: rwideman@uark.edu 511 survivors of an LD 50 microparticle injection (MP Select). The pulmonary arterial pressure (PAP) was lower in MP Select than in MP Base broilers. Both lines exhibited similar percentage increases in PAP after microparticles were injected, and AG modestly amplified the PH triggered by microparticles in both lines. In Experiment 3 we evaluated the responses of male progeny from a second base population (PAC Base) and from a derivative line selected for 3 generations using the unilateral pulmonary artery clamp technique (PAC Select). The PAP was lower in PAC Select than in PAC Base broilers, and both lines exhibited similar percentage increases in PAP in response to the microparticles. The PH triggered by microparticles was not amplified by AG but was doubled by L-NAME. These experiments demonstrate that during the 30 min following pulmonary vascular entrapment of microparticles, iNOS modulated the PH elicited in broilers derived from the MP pedigree line, but not in broilers from the PAC pedigree line. Different NOS-mediated responses among broiler populations may affect pulmonary hemodynamic characteristics of broiler lines selected using i.v. microparticle injections. , 2001 , 2005a Chapman and Wideman, 2001 ). Intravenous microparticle injections can be used to eliminate broilers having the most restrictive pulmonary vasculature. The venous blood carries the microparticles to the lungs where they occlude pulmonary arterioles in proportion to the numbers of microparticles injected. Broilers with the most limited pulmonary vascular capacity succumb to respiratory insufficiency within 24 h (pulmonary hypertension, hypoxemia) or develop PHS within 3 wk. Clinically healthy survivors and their progeny exhibit markedly improved performance when compared with unselected broilers under conditions that challenge the pulmonary vasculature by increasing the cardiac output Wideman et al., 2003) .
Ongoing studies seek to characterize key traits that differentiate clinically healthy (resistant) survivors from the susceptible broilers that succumb to microparticle in-jections. Theoretically, broilers with the most robust pulmonary vascular capacity survive primarily because sufficient vascular channels remain unoccluded to convey the cardiac output without requiring an excessive increase in pulmonary arterial pressure (PAP; . In addition to physically occluding pulmonary arterioles, entrapped microparticles can stimulate local tissues and leukocytes to release vasoactive substances capable of altering pulmonary vascular resistance by dilating or constricting the nearby vasculature (Wang et al., 2003; . For example, the enzyme nitric oxide synthase (NOS) generates the potent pulmonary vasodilator nitric oxide (NO), which plays a prominent role in reducing the pulmonary vascular resistance and facilitating increased pulmonary blood flow in chickens (Wideman et al., , 1996 (Wideman et al., , 1998 (Wideman et al., , 2005a MartinezLemus et al., 1999 MartinezLemus et al., , 2003 Ruiz-Feria et al., 2001; Villamor et al., 2002; Wang et al., 2002b; Weidong et al., 2002; Moreno de Sandino and Hernandez, 2003; Odom et al., 2004; . In a recent study the NOS inhibitor N ω -nitro-L-arginine methyl ester (L-NAME) was administered to block NO synthesis prior to injecting microparticles. The increases in pulmonary vascular resistance and PAP induced by microparticles were greater in amplitude and longer in duration in broilers pretreated with L-NAME than in broilers pretreated with saline. Mortality triggered within 48 h postinjection more than doubled when L-NAME was combined with microparticle injection doses that otherwise caused relatively low mortality in the absence of L-NAME. These observations are consistent with the hypothesis that L-NAME reduced or eliminated the modulating influence of NO, thereby amplifying the pulmonary hemodynamic consequences of physical occlusion (Wideman et al., 2005b) .
Sources of NO that modulate the sequelae to microparticle occlusion remain to be identified. Partial occlusion of the pulmonary vasculature forces cardiac output to flow at higher rates through unobstructed blood vessels. Endothelial cells lining the internal surfaces of blood vessels contain constitutively expressed endothelial NOS (eNOS or NOS-3), which is activated when increased blood flow exerts shear stress on the endothelium. Activated eNOS produces NO, which in turn triggers flowdependent vasodilation to reduce the resistance to blood flow (Wideman et al., 1996; Gaston and Stamler, 1997; Arnal et al., 1999; Albrecht et al., 2003) . Entrapped microparticles are rapidly surrounded by mononuclear leukocytes, including monocytes/macrophages and thrombocytes Wang et al., 2003) . Activated monocytes/macrophages can express inducible NOS (iNOS or NOS-2), which is capable of generating copious quantities of NO (Chang et al., 1996; Gaston and Stamler, 1997; Qureshi, 1997, 1998; Palmer et al., 1998; Resta et al., 1999; Pulido et al., 2000; Dil and Qureshi, 2002a,b; Qureshi, 2003; . The L-NAME blocks NO synthesis by both eNOS and iNOS; consequently, L-NAME cannot be used to discriminate between the respective contributions of eNOS vs. iNOS (Ruetten and Thiemermann, 1996; Arnal et al., 1999; Albrecht et al., 2003) .
If intrapulmonary iNOS does produce NO in quantities sufficient to modulate pulmonary hemodynamic responses, then broilers pretreated with the selective iNOS inhibitor aminoguanidine (AG) should exhibit an amplified pulmonary hypertensive response to i.v. microparticle injections. Aminoguanidine is more selective as an iNOS inhibitor than N-nitro-L-Arginine and N-methyl-LArginine but is 30 to 100 times less potent as an inhibitor of constitutive eNOS (Joly et al., 1994; Szabo et al., 1994; Ruetten and Thiemermann, 1996) . Aminoguanidine previously was used to evaluate the impact of inhibiting iNOS during Eimeria tenella infections in chickens (Allen, 1997) and to inhibit iNOS expression and NO production induced by lipopolysaccharide (LPS, endotoxin) in mammalian macrophages, lungs, and blood vessels (Joly et al., 1994; Ruetten and Thiemermann, 1996; Stitt et al., 1997; Numata et al., 1998; Scott and McCormack, 1999; Pulido et al., 2000) . Experiment 1 was conducted to confirm the ability of AG to inhibit LPS-stimulated NO synthesis by peripheral blood mononuclear leukocytes from broilers. In Experiment 2 we evaluated the effect of AG on the pulmonary hypertensive response to microparticles injected into male broiler progeny from a base population (MP Base) and from a derivative line selected for 1 generation from the survivors of an LD50 microparticle injection (MP Select; Wideman et al., 2003) . In Experiment 3 we evaluated male progeny from a second base population (PAC Base) and from a derivative line selected for 3 generations using the unilateral pulmonary artery clamp technique (PAC Select; French, 1999, 2000; .
MATERIALS AND METHODS
Male broiler chicks were transported on the day of hatch (01/22/04, 04/01/04, and 9/22/04 for Experiments 1, 2, and 3, respectively) to the Poultry Environmental Research Laboratory at the University of Arkansas Poultry Research Farm, where they were placed on fresh wood shavings litter in environmental chambers (8 m 2 floor space). Chicks were brooded at 33°C on d 1 to 5, 29°C on d 6 to 10, and 23.8°C (75°F) thereafter. They were fed a 23% CP corn-soybean meal-based broiler ration formulated to meet National Research Council (1994) standards for all ingredients, including 1.51% arginine and 1.48% lysine. Feed and water were provided for ad libitum consumption. 
Experiment 1: Peripheral Blood Mononuclear Cell Responses
Venous blood samples (3 mL) were obtained from 10 clinically healthy male broilers at 24 d of age using heparinized syringes. The blood was diluted in 3.0 mL of sterile Dulbecco's PBS (DPBS) in sterile siliconized glass centrifuge tubes (Atlanta Biologicals, Norcross, GA). The 6 mL blood dilution was layered on top of 6 mL of Fico/ Lite LymphoH (Ficoll; Atlanta Biologicals) and centrifuged at 350 × g for 30 min at room temperature. After centrifugation, the layer of peripheral mononuclear cells (PMNC) at the plasma-Ficoll interface was harvested using a Pasteur pipette and added to 10 mL of cold DPBS. This mixture was washed by centrifuging at 250 × g at 4°C for 8 min. After centrifugation, the supernatant fluid was discarded, and the PMNC pellet was resuspended in 10 mL of DPBS and washed again. After the final wash the cells were resuspended in 1 mL of complete RPMI 1640 without phenol red (Gibco BRL Products, Grand Island, NY) supplemented with 5% fetal bovine serum and 1% fungizone/pen/strep/L-glutamine (Atlanta Biologicals; culture medium). A cell count was performed using a hemacytometer and a 1:10 (20L of cell suspension in 180 L of 0.04% Trypan Blue stain) dilution of cell suspension to determine the concentration of living PMNC (monocytes, lymphocytes, and thrombocytes). The PMNC concentration was adjusted with culture medium to 1 × 10 7 viable cells per 1 mL. Cells were cultured in Costar Corning Incorporated 96-well cell round bottom tissue culture nonpyrogenic polystyrene plates (VWR International, Suwanee, GA). For each sample, the following cultures were set up in triplicate wells in a total volume of 220 L/well: unstimulated control cultures containing 200 L of cells (2 × 10 6 /well) and 20 L of culture medium, LPS-stimulated cultures containing 200 L of cells and 20 g of LPS from Salmonella typhimurium (Atlanta Biologicals), unstimulated and LPS-stimulated cultures containing 1 mM L-NAME (Sigma Chemical Co., St. Louis, MO), unstimulated and LPS-stimulated cultures containing 1 mM AG (Cayman Chemical Co., Ann Arbor, MI). Based on preliminary dose response tests, the LPS dose used here to stimulate PMNC in vitro was found to be the lowest amount of LPS that reliably resulted in maximal NO production by PMNC (2 × 10 6 cells) from young broilers. The cultures were incubated for 24 h at 41°C and 5% CO 2 in a humidified tissue culture incubator. After incubation the plates were centrifuged at 250 × g for 8 min at 4°C. The supernatant culture fluid was then analyzed by nitrite assay to determine the concentration of NO produced during the 24-h culture (Gore and Qureshi, 1997) . Briefly, 100 L of supernatant fluid from each well was transferred from the culture plates into the corresponding wells of a 96-well flat bottom plate. Known amounts of sodium nitrite (standards) were added in duplicate to each plate at concentrations of 1.25, 2.5, 5, 10, 20, 30, 40, 50, 60, 70, 80 , and 90 M sodium nitrite/well. One hundred microliters of Griess Reagent was added to the samples and standards and the mixtures were allowed to incubate for 8 min. The intensity of the colorogenic reaction was analyzed at a wavelength of 540 nm using a BioTek Powerwave 340 microplate reader (Bio-Tek Instruments, Inc., Highland Park, VT). A standard curve describing the linear relationship between nitrite concentration (M) and color intensity was then constructed using the absorbance units for each standard concentration. The equation of this line was determined and, together with the absorbance units obtained for each culture, used to calculate the concentration of nitrite in each culture supernate.
Pilot studies also were conducted to determine whether NO production by LPS-stimulated monocytes can be inhibited within 30 min by AG. Blood samples from 4 birds were used to prepare PMNC cultures as described previously. Two-hundred microliters of PMNC at 1 × 10 7 cells/mL were placed in sterile siliconized centrifuge tubes with 10 L of 2 mg/mL LPS (stimulated cultures) or 10 L of PBS (unstimulated) and incubated for 30 min or 6 h in a humidified incubator at 40°C with 5% CO 2 . After incubation, 10 L of PBS with or without 1.5 mM AG was added to each culture. To detect NO production, 2 M DAF-FM diacetate (4-amino-5-methylamino-2′,7′-difluorescein diacetate; Molecular Probes, Inc., Eugene, OR) was added to the cell suspension in each tube, and cultures were maintained at room temperature for 20 min. The DAF-FM diacetate passively diffuses across the cell membrane and reacts with esterases present in the cell to form DAF-FM. The reaction between DAF-FM and NO generates fluorescence and, hence, individual NOproducing cells can be detected by flow cytometry. After incubation, 8 mL of cold PBS was added to the cell suspension in each tube, and cells were centrifuged at 250 × g at 4°C for 8 min. The supernatant fluid was discarded, the pellet was resuspended in 0.5 mL of PBS, and each cell suspension was transferred into 5-mL Falcon tubes (Becton Dickinson and Co., San Jose, CA) for fluorescence analysis using a Becton Dickinson FACSort flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA) equipped with a 488-nm argon laser. Cell population analysis was conducted using the CellQuest software (Becton Dickinson Immunocytometry Systems). Positive fluorescence (NO-production) was consistently detected in the monocyte population. Additionally, cells from these cultures were subjected to propidium iodide staining and direct immunofluorescent staining with phycoerythrin-labeled mouse-anti-chicken monocyte-/macrophage-specific monoclonal antibody (KUL01, Southern Biotechnology Associates, Inc., Birmingham, AL) to determine the percentage of dead cell and monocytes in the PMNC cultures, respectively (Erf et al., 1998) . Data were reported as the percentage of fluorescing cells within the monocyte population.
Experiment 2: MP Base and Select Lines
Male progeny from the MP Base population (a pedigree male line) and from MP Select were used in this experiment. Between 39 and 46 d of age, 18 clinically healthy MP Base and 18 clinically healthy MP Select birds were weighed and prepared for surgery as described previously (Wideman et al., 1996 . All birds had full access to feed and water until they were anesthetized. A surgical plane of anesthesia was induced with intramuscular injections of allobarbital (5,5-diallyl-barbituric acid, Sigma Chemical Co.; 16 mg/ kg of BW) and ketamine HCl (50 mg/mL, 40 mg/kg of BW; Bedford Laboratories, Bedford, OH). The birds were fastened in dorsal recumbency on a surgical board, and Silastic tubing (0.012 in I.D., 0.037 in O.D.) filled with heparinized saline [150 units of ammonium heparin (Sigma Chemical Co.) per mL of 0.9% NaCl] was inserted through the left basilica vein (wing vein). The distal end of the Silastic tubing was attached to a blood pressure transducer interfaced through a Transbrige preamplifier (World Precision Instruments, Sarasota, FL) to a Biopac MP100 data acquisition system using AcqKnowledge software (Biopac Systems, Inc., Santa Barbara, CA). The Silastic cannula was advanced into the right pulmonary artery by monitoring the characteristic pulse pressures to identify its location ). PE-50 polyethylene tubing filled with heparinized saline was inserted into the left wing vein for i.v. injections. Ongoing i.v. infusions were not administered. After surgical preparations were complete and a stabilization period of 10 min had elapsed, control data were recorded for 10 min. The broilers then were injected i.v. with either 1 mL of 0.9% saline alone (MP control groups: 9 Base and 9 Select birds), or 100 mg of AG (Cayman Chemical Co.) dissolved at 100 mg/mL in 0.9% saline (MP AG groups: 9 Base and 9 Select birds). After 15 min, all birds were injected i.v. with 0.30 mL of microgranular CM-32 ion exchange cellulose microparticles (30 m average particle diameter; Fisher Scientific, St. Louis, MO) suspended at 0.02 g/mL in heparinized saline. The microparticles were added to the heparinized saline <10 min prior to injection and were maintained in uniform suspension by continuous stirring on a magnetic stirring plate. An aliquot of the suspension was drawn into a 1 mL tuberculin syringe through an attached 22-gauge needle; 0.30 mL of the suspension was injected via the wing vein cannula; and 0.4 mL of heparinized saline then was injected to flush residual particles from the cannula. Previous studies demonstrated that approximately 0.3 to 0.35 mL of the 0.02 g/mL cellulose microparticle suspension is required to significantly elevate the PAP, triggering <10% mortality within 24 h postinjection in 6-to 7-wk-old male broilers Wideman et al., 2005b) . Injection dosages were not adjusted for individual differences in BW because indices of lung volume (and thus presumably pulmonary vascular capacity) are poorly correlated with body mass in broilers of the same age (Julian, 1989; Owen et al., 1995) . Extensive practical experience has not revealed correlations between the preinjection BW of broilers of the same age and the sequelae to constant-dose microparticle injections . Data were recorded for 30 min following the microparticle injection, and the experiments were terminated with a 10 mL i.v. injection of 0.1 M KCl. The heart was dissected to obtain ventricular weights for calculating the right:total ventricular weight ratio (RV:TV) as an indirect index of PAP. Under a wide variety of conditions, clinically healthy domestic fowl with normal PAP have RV:TV ranging between 0.15 and 0.27, whereas sustained pulmonary hypertension causes RV:TV to increase > 0.28 (Huchzermeyer and DeRuyck, 1986; Peacock et al., 1989; Julian, 1993; Lubritz et al., 1995; Wideman 2000 Wideman , 2001 .
Experiment 3: PAC Base and Select Lines
Male progeny from the PAC base population (a pedigree female line) and from PAC Select were used in this experiment. Body weights, susceptibility to ascites induced by cool temperatures, and PAP for progeny from these lines have been reported previously (Wideman and French, 2000; Chapman and Wideman, 2001; Wideman, 2001) . No further selection pressure for ascites resistance had been imposed on the PAC Select line during the 2 years preceding the present study. Between 33 and 41 d of age, 20 clinically healthy PAC Base and 30 clinically healthy PAC Select birds were weighed, anesthetized, and prepared for recording the PAP as just described. After surgical preparations were complete and a stabilization period of 10 min had elapsed, control data were recorded for 10 min. The broilers then were injected i.v. with either 1 mL of heparinized saline alone (PAC control groups: 10 Base and 10 Select birds), 100 mg of AG dissolved at 100 mg/mL in saline (PAC AG groups: 10 Base and 10 Select birds), or 50 mg of (L-NAME (Cayman Chemical Co.) dissolved at 50 mg/mL in saline (PAC L-NAME group: 10 Select birds). Too few birds were available in the Base population to permit assessment of the responses to L-NAME in this group. Fifteen min later, each bird was injected i.v. with 0.30 mL of microgranular CM-32 ion exchange cellulose microparticles suspended at 0.02 g/mL in heparinized saline. Data were recorded for 30 min following the microparticle injection, and the experiments were terminated with a 10 mL i.v. injection of 0.1 M KCl. The heart was dissected to obtain ventricular weights for calculating RV:TV.
Data Analysis
The SYSTAT (Systat Software Inc.) ANOVA was used to compare the effects of in vitro treatments on NO production by PMNC as assessed by nitrite assay and flow cytometric analyses. In the presence of significant treatment effects, Fisher's LSD multiple mean comparison tests were conducted.
The PAP was averaged electronically during representative sample intervals: at 4, 2, and 0.5 min prior to the saline, AG, or L-NAME injection (sample intervals C1 to C3); within 0.5 min after the saline, AG, or L-NAME injection (AG1) and at 2 min intervals throughout the subsequent 15 min (sample intervals AG2 to AG8); within 0.5, 1, 1.5, 2, 4, 6, 8, 10, 15, 20, 25 , and 30 min after the cellulose microparticle injection (sample intervals MP1 through MP12, respectively); and during the minor and major peak PAP responses that occurred approximately 60 s (peak 1) and 4 to 6 min (peak 2) after the microparticle injection. These sample intervals were selected to capture the essential characteristics of the PAP responses to AG and microparticle injections. The protocol used for data averaging accommodates the influences of pulse pressure and respiratory cycles on PAP (Wideman et al., 1996) . Data were analyzed within a group over time (across sample intervals) using the SigmaStat Repeated Measures ANOVA procedure (Jandel Scientific, 1994) . The SigmaStat 2-way ANOVA was used to evaluate line (Base, Select) × treatment (control, AG) interactions. Significant line × treatment interactions were not detected (P = 0.184 for experiment 2; P = 0.944 for Experiment 3). Data were pooled by line independent of treatment, or by treatment independent of line, and differences within individual sample intervals were evaluated by 1-way ANOVA (multiple groups) or t-test (2 groups; Jandel Scientific, 1994) . Differences in proportions were evaluated using the SigmaStat z-test. The threshold for significance was P ≤ 0.05 unless otherwise indicated.
RESULTS

Experiment 1
The nitrite assay data on NO produced by peripheral blood mononuclear leukocytes during 24 h of culture are summarized for each treatment group in Figure 1 , panel A, and for individual broilers in Figure 1 , panel B. The mononuclear leukocytes treated with LPS in the absence of NOS inhibitors produced 10 times more NO than the untreated (control) mononuclear leukocytes. The LPSstimulated production of NO was partially inhibited by L-NAME and was fully inhibited by AG. Adding L-NAME or AG in the absence of LPS did not affect basal NO production when compared with the control treatment ( Figure 1, panel A) . The incomplete inhibition of LPSstimulated NO production by L-NAME can be attributed to the same 3 individuals' mononuclear leukocytes that also exhibited the greatest response to LPS in the absence of L-NAME (Figure 1, panel B) .
The PMNC cultures that remained unstimulated or were stimulated for 30 min or 6 h with LPS, subsequently were analyzed by flow cytometry 30 min after the addition of AG to the culture medium. Adding AG to unstimulated cultures did not reduce the percentage of monocytes producing NO (unstimulated: 9.2 ± 2.5%; unstimulated + AG: 6.8 ± 1.8%). Stimulating the PMNC cultures with LPS for 30 min increased (P = 0.028) the percentage of NO producing monocytes to 16.6 ± 3.3%, and adding AG to LPS-stimulated cultures numerically reduced the percentage of NO producing monocytes to 13.9 ± 1.5% (P = 0.392). Stimulating the PMNC cultures with LPS for 6 h increased (P = 0.001) the percentage of NO producing monocytes from 7.6 ± 1.5% (unstimulated) to 43.1 ± 3.6%. Adding AG for 30 min to the cultures that had been stimulated for 6 h with LPS reduced (P = 0.052) the percentage of NO producing monocytes to 27.4 ± 9.5%. The percentage of dead cells in the PMNC cultures was not affected by treatments (88 to 90% viability).
Experiments 2 and 3
Body weights, control PAP, and heart weights are shown in Table 1 . Broilers in the MP lines were approxi- mately a week older and ≥60% heavier than those in the PAC lines. No differences in BW were observed between the MP Base and MP Select lines, or between the PAC Base and PAC Select lines. Differences in BW tended to correspond to proportional differences in the total ventricle weight, but the relative total ventricle weight (total ventricle weight divided by BW) did not differ among lines. Broilers in the MP Base line had the highest values for absolute and relative right ventricle weight, RV:TV, and control PAP, whereas broilers in the PAC Table 1 . Body weight, control pulmonary arterial pressure (PAP), right:total ventricular weight ratio (RV:TV), and absolute or relative right (RV, RV/BW), left (LV, LV/BW), and total (TV, TV/BW) ventricle weight for male progeny from 4 broiler lines: Base population A (MP Base) from which a resistant line was selected using intravenous microparticle injections (MP Select); and base population B (PAC Base) from which a resistant line was selected using the unilateral pulmonary artery clamp technique (PAC Select) (Table 1) . A representative recording of the PAP response to AG and microparticle injection in Experiment 2 is shown in Figure 2 . Aminoguanidine stabilized but did not increase the PAP during the period preceding microparticle injection. The microparticle injection triggered a minor peak in PAP within 50 s (peak 1) followed by the major pulmonary hypertensive response (peak 2 and thereafter). Group means for the absolute PAP and per- Figure 2 . Recording of the pulmonary arterial pressure of a male broiler in Experiment 2 during an initial control period, after an i.v. injection of 100 mg of aminoguanidine, and for 30 min after an i.v. injection of cellulose microparticles (0.30-mL cells). Injecting the microparticles elicited a minor pulmonary hypertensive peak (peak 1) that was followed by the major response (peak 2).
centage change in PAP are shown in Figure 3 . The PAP did not differ between groups, nor did it vary within any group over time during control sample intervals (C1 to C3) or following the saline and AG injections (sample intervals AG1 to AG3). The microparticle injection increased the PAP in all groups (sample intervals MP1 to MP3 compared with AG8). Within 1 min postmicroparticle injection (sample interval MP2), both of the groups treated with AG exhibited a greater percentage increase in PAP than did the saline-injected Select group. Thereafter the Base group that had been injected with AG had a higher absolute PAP (sample intervals peak . Data were averaged electronically during representative sample intervals at 4, 2, and 0.5 min prior to injecting saline or aminoguanidine (sample intervals C1 to C3); within 0.5 min after injecting saline or aminoguanidine (AG1) and at 2 min intervals throughout the subsequent 15 min (sample intervals AG2 to AG8); within 0.5, 1, 1.5, 2, 4, 6, 8, 10, 15, 20, 25, and 30 min after injecting microparticles (sample intervals MP1 through MP12, respectively); and during the minor and major peak responses (peaks 1 and 2; mean ± SEM; n = 9 per group). Asterisks (*) denote the earliest postinjection values that were higher than the respective preinjection values (C3 vs. AG1 to AG8; or AG8 vs. MP1 to MP12) within a group (P ≤ 0.05). Different letters (a, b) designate group means that differed within a sample interval (P ≤ 0.05). Probability values that approached but did not attain significance at P ≤ 0.05 are indicated.
2, MP6 to MP10) and a greater percentage increase in PAP (sample intervals MP7 and MP8) when compared with the Select group that had been injected with saline ( Figure 3) . Line × treatment interactions were not observed; therefore the groups were pooled by line independent of saline or AG treatment. Broilers in the Base line maintained a higher absolute PAP than broilers in the Select line throughout the experiment, but the percentage increase in PAP following the microparticle injections was not greater in the Base than in the Select broilers (Figure 4 ). Pooling the groups by saline or AG treatment, independent of line, demonstrated that i.v. microparticles triggered a greater percentage increase in PAP in the broilers injected with AG when compared with saline ( Figure 5 , sample intervals MP1 to MP4 and peak 2 to MP10). (PAP, panel B) in Experiment 2 for groups pooled by line (MP Base, MP Select) independent of saline or aminoguanidine treatment. Data were averaged electronically during representative sample intervals at 4, 2, and 0.5 min prior to injecting saline or aminoguanidine (sample intervals C1 to C3); within 0.5 min after injecting saline or aminoguanidine (AG1) and at 2 min intervals throughout the subsequent 15 min (sample intervals AG2 to AG8); within 0.5, 1, 1.5, 2, 4, 6, 8, 10, 15, 20, 25, and 30 min after injecting microparticles (sample intervals MP1 through MP12, respectively); and during the minor and major peak responses (peaks 1 and 2; mean ± SEM; n = 18 per group). Asterisks (*) denote the earliest postinjection values that were higher than the respective preinjection values (C3 vs. AG1 to AG8; or, AG8 vs. MP1 to MP12) within a group (P ≤ 0.05). Different letters (a, b) designate group means that differed within a sample interval (P ≤ 0.05). Probability values that approached but did not attain significance at P ≤ 0.05 also are indicated.
Group means for the absolute PAP and percentage change in PAP in Experiment 3 are shown in Figure 6 . During control sample intervals the PAP was higher in both PAC Base groups than in 2 of the 3 PAC Select groups. Group differences diminished 2 min after injecting AG or L-NAME, both of which increased the absolute PAP in broilers from the PAC Select line (sample interval AG2 compared with C1 to C3). The response to AG per se was transient in PAC Select broilers, whereas a modest but sustained percentage increase in PAP occurred in response to L-NAME (sample intervals AG1 to AG5, AG7 to AG8). Microparticle injections increased the PAP in each of the groups (sample interval AG8 compared with MP1 and thereafter). Within 4 min postmicroparticle injection (sample interval MP5), both of the PAC Base groups as well as the PAC Select group treated with L-NAME had higher absolute PAP than did the PAC Select group treated with AG. Thereafter the PAC Base group treated with AG and the PAC Select group treated with L-NAME had higher PAP than the remaining PAC Select groups (sample intervals peak 2 to MP12). The percentage increase in PAP was higher (PAP, panel B) in Experiment 2 for groups pooled by saline or aminoguanidine treatment (all control, all aminoguanidine) independent of line. Data were averaged electronically during representative sample intervals at 4, 2, and 0.5 min prior to injecting saline or aminoguanidine (sample intervals C1 to C3); within 0.5 min after injecting saline or aminoguanidine (AG1) and at 2-min intervals throughout the subsequent 15 min (sample intervals AG2 to AG8); within 0.5, 1, 1.5, 2, 4, 6, 8, 10, 15, 20, 25 , and 30 min after injecting cellulose microparticles (sample intervals MP1 through MP12, respectively); and, during the minor and major peak responses (peaks 1 and 2; mean ± SEM; n = 18 per group). Asterisks (*) denote the earliest postinjection values that were higher than the respective preinjection values (C3 vs. AG1 to AG8; or AG8 vs. MP1 to MP12) within a group (P ≤ 0.05). Different letters (a, b) designate group means that differed within a sample interval (P ≤ 0.05). Probability values that approached but did not attain significance at P ≤ 0.05 also are indicated.
in the PAC Select broilers treated with L-NAME than in any of the remaining groups throughout the postmicroparticle sample intervals ( Figure 6 ). Pooling groups by line independent of saline or AG treatment (not including the PAC Select L-NAME group) demonstrated that broilers in the PAC-Base line maintained a higher absolute PAP than broilers in the PAC-Select line throughout the experiment. The percentage increase in PAP following the microparticle injections was greater in the PAC Base than in the PAC Select line during sample interval MP5 (Figure 7 ). Pooling the groups by saline or AG treatment, independent of line (not including the PAC Select L-NAME group), demonstrated that i.v. microparticles triggered similar absolute and percentage increases in PAP (Figure 8 , sample intervals MP1 to MP4 and peak 2 to MP10).
Individual Values for Experiments 2 and 3
Revealing the variation among individuals within a genetic line is important for assessing the impact of a Figure 6 . Absolute pulmonary arterial pressure (panel A) and percentage change in pulmonary arterial pressure (PAP, panel B) in Experiment 3 for male progeny from base population B (PAC Base) and from a derivative line selected for 3 generations using the unilateral pulmonary artery clamp technique (PAC Select). Data were averaged electronically during representative sample intervals at 4, 2, and 0.5 min prior to injecting saline, aminoguanidine, or L-NAME (sample intervals C1 to C3); within 0.5 min after injecting saline, aminoguanidine, or L-NAME (AG1) and at 2 min intervals throughout the subsequent 15 min (sample intervals AG2 to AG8); within 0.5, 1, 1.5, 2, 4, 6, 8, 10, 15, 20, 25 , and 30 min after injecting microparticles (sample intervals MP1 through MP12, respectively); and during the minor and major peak responses (peaks 1 and 2; mean ± SEM; n = 10 per group). Asterisks (*) denote the earliest postinjection values that were higher than the respective preinjection values (C3 vs. AG1 to AG8; or AG8 vs. MP1 to MP12) within a group (P ≤ 0.05). Different letters (a, b) designate group means that differed within a sample interval (P ≤ 0.05).
selection strategy. Accordingly, the ranges of individual values obtained for control PAP (average of sample intervals C1 to C3), peak 2 percentage increases in pulmonary arterial pressure, and RV:TV values are illustrated in Figure 9 . Comparing the data for the MP Base and MP Select lines it is evident that the MP Select line has a lower mean value for control PAP ( Table 1) (PAP, panel B) in Experiment 3 for groups pooled by line (PAC Base, PAC Select) independent of saline or aminoguanidine treatment (the PAC Select L-NAME group was not included). Data were averaged electronically during representative sample intervals at 4, 2, and 0.5 min prior to injecting saline or aminoguanidine (sample intervals C1 to C3); within 0.5 min after injecting saline or aminoguanidine (AG1) and at 2 min intervals throughout the subsequent 15 min (sample intervals AG2 to AG8); within 0.5, 1, 1.5, 2, 4, 6, 8, 10, 15, 20, 25 , and 30 min after injecting cellulose microparticles (sample intervals MP1 through MP12, respectively); and during the minor and major peak responses (peaks 1 and 2; mean ± SEM; n = 20 per group). Asterisks (*) denote the earliest postinjection values that were higher than the respective preinjection values (C3 vs. AG1 to AG8; or AG8 vs. MP1 to MP12) within a group (P ≤ 0.05). Different letters (a, b) designate group means that differed within a sample interval (P ≤ 0.05). Probability values that approached but did not attain significance at P ≤ 0.05 also are indicated. PAP averaged 25.5 mmHg. More birds in the PAC Select line (26/30 = 87%) had control PAP values lower than this average compared with the MP Select line (8/18 = 44.4%, P = 0.005) or the MP Base line (2/18 = 11%, P = 0.001), whereas the PAC Base line (12/20 = 60%) did not differ from the PAC Select line or MP Select line (P = 0.063). A similar pattern was obtained for comparisons of RV:TV at the key pulmonary hypertensive threshold of 0.28 (Figure 9, panel C) . All of the birds in the PAC Select line (30/30 = 100%) had RV:TV values below this threshold, whereas fewer birds in the MP Select (14/18 = 78%, P = 0.032) and MP Base lines (11/ 18 = 61%, P = 0.001) had subhypertensive RV:TV. Individual PAP and RV:TV values were not significantly correlated within the separate groups (data not shown), but the correlation for all groups combined was significant with a weakly predictive coefficient of determination (r 2 = 0.325, P = 0.001, Figure 9 , panel D). It is likely that the earliest onset of pulmonary hypertension precedes by days or weeks the increase in right ventricular mass that reflects chronic work hypertrophy. Indeed, many of the individual broilers with PAP values ex- (PAP, panel B) in Experiment 3 for groups pooled by saline or aminoguanidine treatment (all control, all aminoguanidine) independent of line. Data were averaged electronically during representative sample intervals at 4, 2, and 0.5 min prior to injecting saline or aminoguanidine (sample intervals C1 to C3); within 0.5 min after injecting saline or aminoguanidine (AG1) and at 2 min intervals throughout the subsequent 15 min (sample intervals AG2 to AG8); within 0.5, 1, 1.5, 2, 4, 6, 8, 10, 15, 20, 25 , and 30 min after injecting microparticles (sample intervals MP1 through MP12, respectively); and during the minor and major peak responses (peaks 1 and 2; mean ± SEM; n = 20 per group). Asterisks (*) denote the earliest postinjection values that were higher than the respective preinjection values (C3 vs. AG1 to AG8; or AG8 vs. MP1 to MP12) within a group (P ≤ 0.05). Different letters (a, b) designate group means that differed within a sample interval (P ≤ 0.05). Probability values that approached but did not attain significance at P ≤ 0.05 also are indicated.
ceeding 25 mmHg did not exhibit RV:TV values exceeding 0.28 (Figure 9, panel D) . Neither the control PAP nor the RV:TV ratio was predictive of the maximal percentage increase in PAP induced by i.v. microparticles ( Figure 9, panel B) .
DISCUSSION
Significant positive correlations between cardiac output, body weight, and total ventricle weight in 4-to 6-wk-old broilers (Wideman, 1999) , coupled with the current observation that relative total ventricle weights did not differ among the MP and PAC Base and Select lines (Table 1) , suggests the cardiac output per unit of BW is similar among these lines. Differences in relative total ventricle weight also were not detected when the survivors of an LD 50 microparticle selection were compared with uninjected flock mates (Chapman et al., 2005) . In contrast, marked differences in PAP were demonstrated between the MP and PAC Base and Select lines. Pulmonary arterial pressure was lower in progeny from MP Select line (Experiment 2) and in progeny from the PAC Select line (Experiment 3), when compared with progeny from the respective MP Base and PAC Base populations (Table 1) . After microparticles were injected, both the MP Select and PAC Select lines exhibited pulmonary hypertensive responses that paralleled but remained lower than the absolute increases in PAP exhibited by their respective base populations (Figures 4 and 7, panel A) . Recalculating these data to reflect the percentage change in PAP failed to reveal a consistent tendency for base populations to exhibit higher percentage increases after microparticle injections when compared with the respective select lines (Figures 4, 7, and 9; panel B) . These responses mirror observations from independent experiments in which i.v. LPS elicited similar percentage increases in PAP when broilers in a clinically healthy group that had PAP averaging 21 mmHg were compared with those in a hypertensive group whose PAP averaged 29 mmHg (Chapman et al., 2005) . Parallel responses also were observed when clinically healthy and pulmonary hypertensive groups were infused with prostacyclin or provided 100% oxygen to breathe Wideman et al., , 2005a , or during the pulmonary hypertensive response to i.v. LPS when broilers that previously had been injected with microparticles were compared with their uninjected flock mates (Wang et al., 2002a; Chapman et al., 2005) . Pulmonary vascular responses to microparticle entrapment, LPS stimulation, and changes in atmospheric oxygen levels encompass a multitude of cell-and tissue-specific biochemical cascades and involve a broad spectrum of vasoactive mediators and modulators . Therefore either the key differences between PHS-susceptible and -resistant broilers are remarkably subtle, or these differences are unrelated to the physiological and pharmacological challenges that have been evaluated to date. Alternatively, resistance to PHS may be determined primarily by the innate anatomical characteristics of the lungs, particularly as related to the total numbers and compliance of vascular channels that are available to accommodate pulmonary blood flow (Wideman and Bottje, 1993) . Clearly an anatomically robust pulmonary vascular capacity should enable broilers to maintain a lower absolute PAP throughout a variety of challenging conditions.
Maintaining a low PAP reduces the risk of exceeding the 40 to 45 mmHg threshold at which regurgitation by the monocuspid right atrio-ventricular valve protects the pulmonary vasculature from exposure to higher pressures but also compromises the cardiac output and initiates the central venous hypertension (right-sided congestive heart failure) that ultimately progresses to terminal PHS in broilers (Wideman and Bottje, 1993; Wideman et al., , 2003 Wideman et al., , 2005b Wideman and French, 2000; Chapman and Wideman, 2001; Chapman et al., 2005) . The magnitude of the pulmonary hypertension triggered by sublethal i.v. microparticle injections reflects the increase in pulmonary vascular resistance attributable to physical occlusion of precapillary arterioles, as modified by the milieu of vasoactive mediators produced by local tissues and activated leukocytes (see introduction). Previous results support the hypothesis that microparticle entrapment elicits NO production in quantities sufficient to lower the pulmonary vascular tone and partially attenuate the ensuing pulmonary hypertension (Wideman et al., , 2005b . The selective inhibitor AG was used in this study to determine if iNOS expression by activated leukocytes and endothelial cells influenced the acute pulmonary hypertensive response to microparticles. Within this context it is relevant that on a per-enzyme-molecule basis, iNOS is capable of generating 1000-fold more NO than constitutively expressed and transiently activated eNOS (Pulido et al., 2000; Albrecht et al., 2003) . Experiment 1 confirmed the ability of 1 mM AG to fully inhibit LPS-stimulated NO synthesis by broiler mononuclear leukocytes in vivo. The LPS-mediated induction of iNOS expression in chicken monocytes/macrophages has been demonstrated previously (Dil and Qureshi, 2002a,b; Qureshi, 2003) , as has the ability of 1 mM AG to preferentially (e.g., when compared with 1 mM L-NAME) inhibit both LPS-stimulated NO production and iNOS expression by mammalian macrophages and lung tissues (Szabo et al., 1994; Ruetten and Thiemermann, 1996) . For the in vivo experiments, broilers were injected i.v. with 100 mg of AG (approximately 30 mg per kg of BW in Experiment 2, and 50 mg per kg of BW in Experiment 3), which is 10 times the 3 mg/kg of BW daily i.p. injection dosage previously administered to inhibit iNOS in broilers (Allen, 1997) and is comparable with the range of dosages administered in vivo to inhibit basal and LPS-stimulated iNOS activity in mammalian lungs (Ruetten and Thiemermann, 1996; Stitt et al., 1997; Numata et al., 1998; Scott and McCormack, 1999; Evgenov et al., 2000) . In Experiment 2, pretreatment with AG caused broilers of both MP lines to respond similarly with modestly amplified pulmonary hypertensive responses to i.v. microparticle injections ( Figure 5 ). Therefore, responsiveness to AG was not specific to either MP line but might have been characteristic of the original pedigree line. In contrast, neither of the PAC lines evaluated in Experiment 3 exhibited changes in pulmonary hemodynamics that were consistently attributable to pretreatment with AG, whereas pretreatment with L-NAME doubled the pulmonary hypertension triggered by microparticles (Figures 6 and 8 ). These observations are consistent with the hypothesis that during the 30 min immediately following pulmonary vascular entrapment of microparticles, NO produced by iNOS modestly helped reduce the pulmonary vascular resistance in broilers from the MP Base and MP Select lines, but not in broilers from the PAC Base and PAC Select lines.
The wide range of PAP and RV:TV observed within the MP Base and Select lines indicate that several additional generations of selection will be required to achieve a more healthy pulmonary hemodynamic status comparable to the ≤25 mmHg of PAP and ≤0.28 RV:TV currently enjoyed by the majority of broilers in the PAC Select line (Figures 9, panels A and C) . If ongoing selection at the LD 50 intensity continues to be applied, care must be exercised to monitor potential shifts in the expression of both eNOS and iNOS. For example, broilers are most likely to survive microparticle injections if their endothelial cells express more eNOS and if their leukocytes possess inflammatory response profiles that have been shifted toward enhanced recognition and removal activity (more rapid clearance of particles from the vasculature), enhanced vasodilator production (e.g., increased iNOS expression), and attenuated vasoconstrictor production 2005b) . As a caveat, substantial evidence exists that chronic iNOSmediated overproduction of NO damages tissues due to the formation of peroxynitrite and other reactive nitrogen species. Indeed, copious NO production is a key component of the cytotoxicity exerted by activated monocytes/macrophages (Szabo et al., 1994; Gaston and Stamler, 1997; Numata et al., 1998; Evgenov et al., 2000; Albrecht et al., 2003; . Our comparisons of the base and select lines derived from 2 different pedigree sources provided no consistent evidence that increased iNOS activity had been unintentionally coselected along with improvements in pulmonary vascular capacity; nevertheless, unforeseen consequences may eventually surface. Comparing the impact of AG vs. L-NAME in the present and previous studies (Wideman et al., 2005b ) leads us to conclude that vasodilation attributable to eNOS rather than iNOS most likely predominates during the acute (30 min postinjection) response to microparticle injections. A modest role for iNOS in modulating the pulmonary hypertensive response was revealed in broilers derived from 1 pedigree line but not in broilers derived from a second pedigree line.
A number of factors must be considered in assessing the different responses to AG by the 2 pedigree lines we evaluated. Different expression profiles for iNOS vs. eNOS among pedigree lines potentially affect the pulmonary hemodynamic and innate immune responses of broilers selected using the microparticle injection technique. The MP Base and MP Select broilers received a lower relative AG dose (approximately 30 mg/kg of BW) than did the PAC Base and PAC Select broilers (approx. 50 mg/kg of BW); therefore, the absence of consistent impact of AG on the PAC lines cannot be attributed to the dose administered. Aminoguanidine is widely recognized as a selective iNOS inhibitor; nevertheless, excessively high doses of AG can partially inhibit the constitutive eNOS isoform (Joly et al., 1994; Szabo et al., 1994; Ruetten and Thiemermann, 1996; Scott and McCormack, 1999) . Any spillover inhibition of eNOS by AG should have been more pronounced in the younger PAC broilers that received a proportionally higher dose of AG per kg of BW. The PAC line clearly was highly responsive to the nonselective NOS inhibitor L-NAME, yet showed no tendency to respond to AG (Figure 6 ). Factors other than the relative dosage of AG appear to have been responsible for the different responses by the 2 pedigree lines.
Most broilers in the MP lines had higher PAP when compared with their respective counterparts in the PAC lines (Table 1; Figure 9 , panel A). Pulmonary hypertension induced by chronic hypoxia consistently has been associated with increased pulmonary eNOS and iNOS expression in rats (Le Cras et al., 1996; Resta and Walker, 1996; Palmer et al., 1998) , although selective iNOS inhibition failed to alter pulmonary vascular tone in 1 study (Resta et al., 1999) . The modest pulmonary hypertensive response to AG exhibited by MP Base and MP Select broilers could be related to enhanced iNOS expression triggered by elevated PAP in these MP lines, but iNOS expression has yet to be evaluated in broiler lungs. In contrast, pulmonary vascular eNOS expression was reduced in broilers that developed ascites when exposed to chronic hypoxia (Moreno de Sandino and Hernandez, 2003) and in humans suffering from primary pulmonary hypertension (Giaid and Saleh, 1995; Loscalzo, 1995) . Intrapulmonary iNOS expression may be minimal unless the lungs have been exposed to an inflammatory stimulus such as LPS, after which increased iNOS and eNOS expression can be detected in pulmonary macrophages, vascular endothelial and smooth muscle cells, and epithelial cells of the airways (Ruetten and Thiemermann, 1996; Resta et al., 1999; Pulido et al., 2000) . After LPS is used to amplify pulmonary iNOS expression in mammals, many but not all studies have demonstrated an increased pulmonary vascular tone or enhanced pulmonary vasoconstrictive responsiveness subsequent to the administration of specific iNOS inhibitors. Such studies demonstrate that NO produced in copious quantities by activated iNOS can act to sustain low pulmonary and systemic vascular resistances (Resta and Walker, 1996; Palmer et al., 1998; Resta et al., 1999; Pulido et al., 2000; Hallemeesch et al., 2003) . The pedigree lines we used in this study were hatched and reared separately; therefore, it is conceivable that pulmonary exposure to an inflammatory stimulus (e.g., respiratory vaccine, or inhaled or translocated LPS) unintentionally enhanced the expression of iNOS in the lungs of MP broilers but not in PAC broilers. Overall, the current evidence suggests that, as is the case in mammals, eNOS rather than iNOS appears to be the primary source of NO that modulates pulmonary hemodynamics in broilers (Wideman et al., 2005b) . The apparently modest impact of iNOS in the MP broiler lines during the early (30 min postinjection) pulmonary hypertensive response to entrapped microparticles does not preclude the possibility that iNOS may exert a more significant impact over time, as lymphocytic activation and infiltration proceed. Intravenously injected cellulose microparticles persist in the pulmonary microvasculature for ≥2 wk, and the entrapped microparticles are most intensively surrounded by macrophages 24 to 48 h postinjection Wang et al., 2003) . Hours rather than minutes may be required after the initial inflammatory stimulus before iNOS expression has been fully upregulated within the responding leukocytes (Stitt et al., 1997) . Indeed, in the present study, exposing PMNC cultures to LPS for 30 min only doubled the percentage of monocytes that were producing NO, whereas exposing PMNC cultures to LPS for 6 h stimulated a 6-fold increase in the percentage of monocytes producing NO. It was in the latter treatment that significant iNOS inhibition occurred within 30 min after the addition of AG.
In conclusion, AG effectively inhibited NO production by iNOS in broiler mononuclear lymphocytes exposed to LPS. Selecting broiler lines for a more robust pulmonary vascular capacity successfully reduced the PAP of 2 broiler lines but, when compared with the respective base populations, did not alter the efficacy of AG or the percentage increase in PAP during the acute response to i.v. microparticle injections. Clearly an anatomically robust pulmonary vascular capacity should enable broilers to maintain a lower absolute PAP throughout a variety of challenging conditions that would overwhelm susceptible broilers having an elevated resistance to pulmonary blood flow. A modest role for iNOS in modulating the acute pulmonary hypertensive response to microparticles was revealed in broilers derived from one pedigree line but not in broilers derived from a second pedigree line. The reasons for the observed difference between pedigree lines remain unclear but may be related to the relative time course or vigor of the innate immune response mounted by mononuclear lymphocytes seeking to neutralize and clear the entrapped particles from the precapillary arterioles. The cumulative evidence does not support the hypothesis that broilers selected for a robust pulmonary vascular capacity have been significantly coselected for enhanced iNOS expression during the acute (30 min postinjection) time frame of the challenge used in the present study; nevertheless, care must be exercised to monitor potential shifts in NOS expression when multiple generations of broilers are selected using microparticle injections.
#2003-35204-13392, and a grant from Hubbard, Walpole, NH.
